LEASE AND LEASE AGREEMENT Between S/K 520 ASSOCIATES The Landlord And FOAMIX PHARMACEUTICALS INC. The Tenant For Leased Premises In October 25th, 2017Lease and Lease Agreement • February 27th, 2018 • Foamix Pharmaceuticals Ltd. • Medicinal chemicals & botanical products • New Jersey
LEASE AND LEASE AGREEMENT, dated as of October 25th, 2017, between S/K 520 ASSOCIATES, a New Jersey partnership, with offices at 520 Route 22, P.O. Box 6872, Bridgewater, NJ 08807 (the “Landlord”), and FOAMIX PHARMACEUTICALS INC., a Delaware corporation, with an office at 520 Route 22, Bridgewater, NJ 08807 (the “Tenant”).
Termination AgreementTermination Agreement • February 27th, 2018 • Foamix Pharmaceuticals Ltd. • Medicinal chemicals & botanical products
This Termination Agreement ("Agreement") is entered into as of July 1, 2017 (the "Effective Date") by and between Foamix Pharmaceuticals Ltd., a company organized under the laws of the State of Israel, whose principal place of business is located at 2 Chaim Holzman St., Rehovot, Israel, (the "Company") and Dr. Dov Tamarkin (“Executive”).
Termination AgreementTermination Agreement • February 27th, 2018 • Foamix Pharmaceuticals Ltd. • Medicinal chemicals & botanical products
This Termination Agreement ("Agreement") is entered into as of July 1, 2017 (the "Effective Date") by and between Foamix Pharmaceuticals Ltd., a company organized under the laws of the State of Israel, whose principal place of business is located at 2 Chaim Holzman St., Rehovot, Israel, (the "Company") and Mr. Meir Eini (“Executive”).
